Matt Thompson MD

Dr. Thompson is a globally recognized vascular surgeon and medical device executive with extensive experience in implantable Class III medical devices. From 2002 to 2016, he served as a leading vascular surgeon at St. George's Hospital in London, where he gained international recognition for his expertise in complex aortic repair. Transitioning to the medical device industry, he held key leadership roles, serving as Chief Medical Officer at Endologix from 2016 to 2021 and being appointed Chief Executive Officer from 2021 to 2025. He currently continues to contribute to Endologix as Chief Medical Officer.

Raja N. Ghanem, PhD MBA

22+ years in the cardiovascular medical device industry leading product management, marketing, clinical, and R&D efforts to bring class II and III medical devices to market in vascular surgery, cardiac rhythm management and electrophysiology. Lead global product manager of the Endologix portfolio of EVAR and Nellix EVAS systems. ​Cofounder of CardioInsight (acquired by Medtronic) and holder of 35+ patents.

Jeff Kasalko, MS

25+ years of experience in the medical device industry developing innovative solutions for endovascular and structural heart solutions. ​Played a pivotal role in the development and successful IDE submission of the Endologix Nellix EVAS system, launch of the Endologix AFX endograft and the advancement of structural heart valves at Edwards Lifesciences.